ABSTRACT
Los objetivos del presente estudio fueron primero evaluar la asociación de dimensiones antropométricas de tórax y tronco con índices espirométricos, segundo, ajustar una ecuación de predicción con dimensiones antropométricas de tronco y tercero, comparar nuestro modelo predictivo con dos ecuaciones diagnósticas. Se evaluaron 59 estudiantes universitarios entre 20 y 40 años, de ambos sexos, sin hábito tabáquico. Las variables consideradas fueron: edad, sexo, peso, estatura, diámetro transverso de tórax, diámetro anteroposterior de tórax, perímetro de tórax, altura de tórax, altura de tronco, flujo espiratorio máximo (FEM), volumen espiratorio forzado en el primer segundo (VEF1) y capacidad vital forzada (CVF). Se utilizó el análisis de regresión múltiple para estimar los valores espirométricos en función de las variables demográficas y antropométricas. La CVF y el VEF1 tienen asociación lineal directa con el diámetro transverso de tórax, altura de tórax, perímetro de tórax y altura de tronco. Se ajustó una ecuación de regresión lineal múltiple que indicó que es posible estimar la CVF y el VEF11 en función de la altura de tronco y el perímetro de tórax para ambos sexos. Estas variables son capaces de explicar el 74 % de los valores de CVF y el 68 % de los valores de VEF1. Al comparar los valores obtenidos por nuestras ecuaciones predictivas con las ecuaciones de referencia nacional observamos que nuestros resultados son más cercanos a los de Quanjer et al. (2012) que a los de Knudson et al. (1983). La altura de tronco y el perímetro de tórax tienen asociación directa con el VEF1 y CVF y son buenos predictores del VEF1 y CVF en estudiantes universitarios. Nuestros valores estimados son más cercanos a las ecuaciones de Quanjer et al. (2012) en comparación a las estimaciones de Knudson (1983).
SUMMARY: The purposes of the present study were first to evaluate the association between anthropometric dimensions of the thorax and trunk with spirometric indices, second, to fit a prediction equation with anthropometric dimensions of the trunk, and third, to compare our predictive model with two diagnostic equations. Fifty-nine university students between 20 and 40 years old, of both sexes and non-smokers were recruited. Variables considered were age, sex, weight, height, chest transverse diameter, chest anteroposterior diameter, chest perimeter, chest height, trunk height, maximum expiratory flow (PEF), forced expiratory volume in the first second (FEV1) and forced vital capacity (FVC). Multiple regression analysis was used to estimate spirometric values based on demographic and anthropometric variables. FVC and FEV1 have a direct linear association with chest transverse diameter, chest height, chest circumference, and trunk height. A multiple linear regression equation was fitted, indicating that it is possible to estimate FVC and FEV1 as a function of trunk height and chest girth for both sexes. These variables can explain 74% of the FVC values and 68% of the FEV1 values. Comparing the values obtained by our predictive equations with the national reference equations, we observe that our results are closer to those of Quanjer et al. (2012) than to those of Knudson et al. (1983). Trunk height and chest circumference have a direct association with FEV1 and FVC and are good predictors of FEV1 and FVC in university students. Our estimated values are closer to Quanjer et al. (2012) than Knudson et al. (1983) prediction equations.
Subject(s)
Humans , Male , Female , Adult , Young Adult , Spirometry , Anthropometry , Torso/anatomy & histology , Torso/physiology , Thorax/anatomy & histology , Thorax/physiology , Vital Capacity/physiology , Forced Expiratory Volume/physiology , Regression AnalysisABSTRACT
BACKGROUND: Fat mass to fat-free mass ratio (FM/FFM) assesses the combined effect of the balance between fat mass and fat-free mass. AIMS: to evaluate the associations beetween FM/FFM and clinical outcomes in asthma and to compare clinical characteristics between individuals with higher and lower FM/FFM. METHODS: 128 participants with asthma underwent anthropometric, spirometry and bioelectrical impedance assessments. Physical activity in daily life (PADL) was assessed by the Actigraph for 7 days. Daily dose of inhaled medication, steps of pharmacological treatment, Asthma Control Questionnaire, Asthma Quality of Life Questionnaire and Hospital Anxiety and Depression Scale were also assessed. Participants were classified into two groups according to the 50th percentile of reference values for FM/FFM. RESULTS: Individuals with higher FM/FFM (n=75) used higher daily doses of inhaled corticosteroids, had worse lung function and fewer steps/day when compared to those with lower FM/FFM (n=53) (P≤0.021). Associations were found between absolute values of FM/FFM with lung function (FEV1 and FVC [liters]): R2=0.207 and 0.364;P<0.0001), and between the categories of lower or higher FM/FFM with steps of medication treatment (Cramer's V=0.218;P=0.016) and level of PADL (Cramer's V=0.236;P=0.009). The highest FM/FFM was a determining factor of physical inactivity (OR: 3.21;95%CI:1.17-8.78) and highest steps of pharmacological treatment (OR: 8.89;95%CI:1.23-64.08). CONCLUSION: Higher FM/FFM is significantly associated with worse clinical characteristics in individuals with asthma, such as higher doses of inhaled corticosteroids, worse lung function and fewer steps/day. Moreover, higher FM/FFM is a determining factor of physical inactivity and the highest steps of pharmacological treatment for asthma.
Subject(s)
Asthma , Body Composition , Humans , Body Mass Index , Quality of Life , Asthma/drug therapy , Electric ImpedanceABSTRACT
INTRODUCTION: Respiratory muscle weakness and ventilatory failure are common complications in patients with amyotrophic lateral sclerosis (ALS) and may lead to death. Respiratory physiotherapy may improve lung function in this population. This study aims to investigate the effects of respiratory physiotherapy on lung function, cough efficacy and functional status of patients with ALS. METHODS AND ANALYSIS: A protocol was published on the International prospective register of systematic reviews (PROSPERO). The research will cover randomised controlled trials, with no language or publication date restriction, available in the following databases: MEDLINE/PubMed, EMBASE, Cochrane Library, Web of Science and Physiotherapy Evidence Database. The research question will be answered using a search strategy adapted for each database. Searches in databases will be conducted from January 2021 to December 2022. Two authors using the Cochrane risk of bias tool for randomised trials V.2 and Grading of Recommendations, Assessment, Development and Evaluations, respectively, will assess risk of bias and quality of evidence independently. According to the results obtained, data will be reported as a meta-analysis or a narrative report. ETHICS AND DISSEMINATION: No previous ethical approval is required for this publication since data used are already published. Results of this review will be disclosed via peer-reviewed publications and conference presentations. PROSPERO REGISTRATION NUMBER: CRD42021251842.
Subject(s)
Amyotrophic Lateral Sclerosis , Respiratory Insufficiency , Amyotrophic Lateral Sclerosis/complications , Amyotrophic Lateral Sclerosis/therapy , Humans , Meta-Analysis as Topic , Physical Therapy Modalities , Randomized Controlled Trials as Topic , Respiratory Insufficiency/etiology , Respiratory Insufficiency/therapy , Review Literature as Topic , Systematic Reviews as TopicABSTRACT
Introdução: a disfunção pulmonar no pós-operatório de cirurgia cardíaca continua sendo uma das mais importantes causas demorbidade, sendo que o comprometimento da função pulmonar, nessa circunstância, é frequente e contribui, significativamente, para o aumento do tempo de permanência hospitalar. O objetivo deste estudo foi avaliar o comportamento da função pulmonar em pacientes adultos hospitalizados, submetidos à cirurgia cardíaca por esternotomia mediana, no momento a alta da unidade tratamento intensivo, comparado ao quarto dia após a alta dessa unidade. Metodologia: o estudo foi realizado em uma unidade de pós-operatório de cirurgia cardiovascular, após aprovação do Comitê de Ética em Pesquisa. O Termo de Consentimento Livre Esclarecido foi obtido em todos os casos. Incluíram-se pacientes maiores de 18 anos, submetidos à cirurgia cardíaca eletiva. A função pulmonar foi realizada na alta da unidade de tratamento intensivo e, posteriormente, repetida no quarto dia. A função pulmonar foi mensurada pela capacidade vital forçada, pico de fluxo expiratório, além de variáveis do exame físico, como frequência respiratória e ausculta pulmonar. Resultados: 94 pacientes foram submetidos à cirurgia cardíaca eletiva via esternotomia mediana. A média (desvio padrão) de idade foi 50,64 (16,53) anos, com predomínio do sexo masculino (52,1%). A mediana (Q1-Q3) do tempo de permanência na unidade de tratamento intensivo foi de 2,00 dias (2,00-3,00), ao passo que a mediana (Q1-Q3) do tempo de permanência hospitalar foi de 6,00 dias (5,00-8,00). A mediana (Q1-Q3) da capacidade vital forçada e do fluxo respiratório, obtida pela espirometria no pós-operatório, no momento da alta, foi significativamente menor quando comparada ao quarto dia após alta da unidade de tratamento intensivo (p< 0,01). O tempo de permanência na unidade, assim como o tempo de permanência hospitalar não impactou na evolução das variáveis de função pulmonar. Conclusão: a função pulmonar é potencialmente reduzida no período inicial após a cirurgia cardíaca, com evolução gradual, e de recuperação lenta, no curso da recuperação cirúrgica. A manutenção desses valores reduzidos a níveis não críticos por um período prolongado no pós-operatório parece não afetar o desempenho dos pacientes, no que tange a capacidade de respirar profundamente e na efetividade de tosse.
Introduction: pulmonary dysfunction in the postoperative period of cardiac surgery continues to be one of the most important causes of morbidity, and the involvement of pulmonary function in this circumstance is frequent and contributes significantly to an increase in the length of hospital stay. Objective: the objective of this study was to evaluate the pulmonary function behavior in hospitalized adult patients submitted to cardiac surgery by median sternotomy at the time of discharge from the intensive care unit, compared to the fourth day after discharge from this unit. Metodology: the study was performed in a postoperative unit of cardiovascular surgery, after approval of the Research Ethics Committee. The Informed Consent Form was obtained in all cases. Patients older than 18 years who underwent elective cardiac surgery were included. Pulmonary function was performed on discharge from the intensive care unit and then repeated on the fourth day. Pulmonary function was measured by forced vital capacity, peak expiratory flow, besides variables of physical examination, such as respiratory rate and pulmonary auscultation. Results: a number of 94 patients underwent elective cardiac surgery via median sternotomy. Mean (standard deviation) of age was 50.64 (16.53) years, with a predominance of males (52.1%). Median (Q1-Q3) of the time spent in the intensive care unit was 2.00 days (2.00-3.00), while the median (Q1-Q3) of the length of hospital stay was 6.00 days (5.00-8.00). Median (Q1-Q3) of forced vital capacity and respiratory flow, obtained by spirometry in the postoperative period at discharge, was significantly lower when compared to the fourth day after discharge from the intensive care unit (p <0.01 ). The length of stay in the unit, as well as the length of hospital stay, did not affect the evolution of pulmonary function variables. Conclusion: pulmonary function is potentially reduced in the initial period after cardiac surgery, with gradual evolution, and slowness in the course of surgical recovery. Maintaining these reduced values at uncritical levels for a prolonged postoperative period does not appear to affect patients' performance with regard to their ability to breathe deeply and in cough effectiveness.
Subject(s)
Humans , Male , Female , Adult , Respiratory Function Tests , Thoracic Surgery , Peak Expiratory Flow Rate , Vital CapacityABSTRACT
Spirometry is a pulmonary function test that allows screening, diagnosis and monitoring of respiratory diseases. This is a simple, non-invasive test that is easy to perform. By quantifying the respiratory volumes and flows, such as forced vital capacity (FVC) or forced expiratory volume in six seconds (FEV6), forced expiratory volume in the first second (FEV1), and the relationship between these parameters (FEV1/FVC or FEV1/FEV6 ratio), obstruction can be detected with high sensitivity and specificity; likewise, it is possible to classify the severity and response to the bronchodilator. This article presents indications, contraindications, and basic concepts for the interpretation of spirometry.
La espirometría es una prueba de función pulmonar que permite el cribado, diagnóstico y monitorización de las enfermedades respiratorias. Esta prueba es sencilla, fácil de realizar y no invasiva. Mediante la cuantificación de los volúmenes y los flujos respiratorios como la capacidad vital forzada (CVF) o volumen espiratorio forzado en seis segundos (VEF6), el volumen espiratorio forzado en el primer segundo (VEF1) y la relación entre estos parámetros (índice VEF1/CVF o VEF1/VEF6) se detecta obstrucción, con alta sensibilidad y especificidad; asimismo, es posible clasificar la gravedad y la respuesta al broncodilatador. En este artículo se exponen indicaciones, contraindicaciones y conceptos básicos para la interpretación de la espirometría.
Subject(s)
Respiration Disorders/diagnosis , Spirometry , Equipment Design , Forced Expiratory Volume , Humans , Spirometry/instrumentation , Spirometry/methods , Vital CapacityABSTRACT
The relaxation rates and contractile properties of inspiratory muscles are altered with inspiratory muscle weakness and fatigue. This fact plays an important role in neuromuscular disorders patients and had never been extensively studied in amyotrophic lateral sclerosis (ALS). In this cross-sectional study, these parameters were investigated non-invasively through nasal inspiratory sniff pressure test (SNIP) in 39 middle stage spinal onset ALS subjects and compared with 39 healthy controls. ALS patients were also divided into three subgroups according to a decline in their percentage of predicted forced vital capacity (FVC%pred) as well as a decline in the ALS functional rating scale score and its respiratory subscore (R-subscore) in order to determine the best parameter linked to early respiratory muscle weakness. When compared with healthy subjects, middle stage ALS subjects exhibited a significantly lower (p < 0.0001) maximum relaxation rate and maximum rate of pressure development (MRPD), as well as a significantly higher (p < 0.0001) tau (τ), contraction time, and half-relaxation time. The results from receiver operating characteristic curves showed that MRPD (AUC 0.735, p < 0.001) and FVC%pred (AUC 0.749, p = 0.009) were the best discriminator parameters between ALS patients with ≤30 and >30 points in the ALS functional rating scale. In addition, 1/2RT (AUC 0.720, p = 0.01), FVC%pred (AUC 0.700, p = 0.03), τ (AUC 0.824, p < 0.0001), and MRPD (AUC 0.721, p = 0.01) were the parameters more sensitive in detecting a fall of three points in the R-subscore. On the other hand, MRPD (AUC 0.781, p < 0.001), τ (AUC 0.794, p = 0.0001), and percentage of predicted of SNIP (AUC 0.769, p = 0.002) were the parameters able to detect a fall in 30% of the FVC%pred in middle stage ALS patients. The contractile properties and relaxation rates of the diaphragm are altered in middle stage spinal onset ALS when compared with healthy subjects. These parameters are able to discriminate between those middle stage ALS subjects with early decline in inspiratory muscle function and those who not.
ABSTRACT
Impulse oscillometry (IOS) is an emerging tool in the study of pulmonary function in respiratory diseases. In this review we compare its usefulness with that of forced spirometry in children. Although these techniques measure different mechanical properties of the respiratory system, -the first, resistance, and the second, flow- they are, undoubtedly, complementary tests.. This review includes a brief description of some comparative studies since 1973, year of the first publication about children; then, with the advent of technology, its application in the mid-80s and 90s made it possible to include reference values in order to establish functional diagnoses. IOS measures airway, pulmonary and thoracic resistance, which is a primary function of the mechanics of ventilation, whereas spirometry measures the flow, which is a secondary function. This principle allows us to understand why IOS indices are more sensitive than those of spirometry
La Oscilometría de Impulso (IOS) es una herramienta emergente en el estudio de la función pulmonar y en esta revisión se compara su utilidad con la espirometría forzada en niños. Aunque ambas técnicas miden diferentes propiedades mecánicas del sistema respiratorio, resistencias la primera y flujos la segunda, tienen un carácter complementario incuestionable. Esta revisión describe brevemente algunos trabajos comparativos a partir de 1973, fecha de la primera publicación en niños y luego con el advenimiento tecnológico, su aplicación a mediados de los 80 y 90 permite incluir valores de referencia para poder establecer diagnósticos funcionales. La IOS se caracteriza por medir resistencia de la vía aérea y toracopulmonar y que desde el punto de vista de la mecánica respiratoria ésta es una función primaria versus los flujos, medidos por espirometría, que son una función secundaria, este principio es el que permite entender porque sus índices son más sensibles que los de la espirometría
Subject(s)
Humans , Child , Oscillometry/methods , Respiratory Tract Diseases/diagnosis , Spirometry/methods , Respiratory Function Tests/methods , Respiratory Tract Diseases/physiopathology , Vital Capacity , Airway Resistance , Forced Expiratory VolumeABSTRACT
Histidine-rich glycoprotein (HRG) is an enigmatic glycoprotein able to interact with a variety of ligands such as IgG, complement components, heparan sulfate, thrombospondin, fibrinogen and plasminogen. HRG is present at high concentrations in plasma and there is evidence indicating that it is able to modulate the course of biological processes such as angiogenesis, fibroblast proliferation, complement activation, coagulation and fibrinolysis. Because these processes are involved in the pathogeneses of lung fibrosis we here analyzed a possible link between HRG and idiopathic pulmonary fibrosis (IPF). We found that plasma concentrations of HRG are significantly diminished in IPF patients compared to healthy subjects. Moreover, we found a positive correlation between HRG plasma levels and forced vital capacity (FVC) values, suggesting that plasma concentration of HRG would be a useful indicator of disease activity in IPF. HRG has been described as a negative acute phase reactant able to accumulate at sites of tissue injury. Hence, we also measured the concentrations of HRG in BAL samples from IPF patients. We found that the concentrations of HRG in samples from IPF patients were significantly higher compared to controls, suggesting that the reduced concentration of HRG in plasma from IPF patients could be due, at least in part, to an enhanced uptake of this protein in the lung.
Subject(s)
Idiopathic Pulmonary Fibrosis/diagnosis , Proteins/metabolism , Biomarkers/metabolism , Bronchoalveolar Lavage Fluid/chemistry , Enzyme-Linked Immunosorbent Assay , Female , Humans , Idiopathic Pulmonary Fibrosis/physiopathology , Male , Middle Aged , Smoking/adverse effects , Smoking/physiopathology , Vital Capacity/physiologyABSTRACT
RATIONALE: The changes in body position can cause changes in lung function, and it is necessary to understand them, especially in the postoperative upper abdominal surgery, since these patients are susceptible to postoperative pulmonary complications. OBJECTIVE: To assess the vital capacity in the supine position (head at 0° and 45°), sitting and standing positions in patients in the postoperative upper abdominal surgery. METHODS: A cross-sectional study conducted between August 2008 and January 2009 in a hospital in Salvador/BA. The instrument used to measure vital capacity was analogic spirometer, the choice of the sequence of positions followed a random order obtained from the draw of the four positions. Secondary data were collected from the medical records of each patient. RESULTS: The sample consisted of 30 subjects with a mean age of 45.2 ± 11.2 years, BMI 20.2 ± 1.0 kg/m2. The position on orthostasis showed higher values of vital capacity regarding standing (mean change: 0.15 ± 0.03 L; p = 0.001), the supine to 45 (average difference: 0.32 ± 0.04 L; p = 0.001) and 0° (0.50 ± 0.05 L; p = 0.001). There was a positive trend between the values of forced vital capacity supine to upright posture (1.68 ± 0.47; 1.86 ± 0.48; 2.02 ± 0.48 and 2.18 ± 0.52 L; respectively). CONCLUSION: Body position affects the values of vital capacity in patients in the postoperative upper abdominal surgery, increasing in postures where the chest is vertical. .
JUSTIFICATIVA: As alterações no posicionamento corporal podem ocasionar mudanças na função respiratória e é necessário compreendê-las, principalmente no pós-operatório abdominal superior, já que os pacientes estão suscetíveis a complicações pulmonares pós-operatórias. OBJETIVO: Verificar a capacidade vital nas posições de decúbito dorsal (cabeceira a 0° e 45°), sentado e em ortostase em pacientes no pós-operatório de cirurgia abdominal superior. MÉTODOS: Estudo transversal, feito entre agosto de 2008 e janeiro de 2009, em um hospital na cidade de Salvador (BA). O instrumento usado para mensuração da capacidade vital (CV) foi o ventilômetro analógico e a escolha da sequência das posições seguiu uma ordem aleatória obtida a partir de sorteio das quatro posições. Os dados secundários foram colhidos nos prontuários de cada paciente. RESULTADOS: A amostra foi composta por 30 indivíduos com idade média de 45,2 ± 11,2 anos e IMC 20,2 ± 1,0 kg/m2. A posição em ortostase apresentou valores maiores da CV em relação à sedestração (média das diferenças: 0,15 ± 0,03 litros; p = 0,001), ao decúbito dorsal a 45° (média das diferenças: 0,32 ± 0,04 litros; p = 0,001) e 0° (0,50 ± 0,05 litros; p = 0,001). Houve um aumento positivo entre os valores de CVF do decúbito dorsal para a postura ortostática (1,68 ± 0,47; 1,86 ± 0,48; 2,02 ± 0,48 e 2,18 ± 0,52 litros; respectivamente). CONCLUSÃO: A posição do corpo afeta os valores da CV em pacientes no pós-operatório de cirurgia abdominal superior, com aumento nas posturas em que o tórax encontra-se verticalizado. .
JUSTIFICACIÓN: Las alteraciones en el posicionamiento corporal pueden ocasionar cambios en la función respiratoria y es necesario comprenderlas, principalmente en el postoperatorio abdominal superior, ya que los pacientes son susceptibles a complicaciones pulmonares postoperatorias. OBJETIVO: Verificar la capacidad vital en las posiciones de decúbito dorsal (cabeza a 0° y 45°), sentado y en ortostasis en pacientes en el postoperatorio de cirugía abdominal superior. MÉTODOS: Estudio transversal realizado entre agosto de 2008 y enero de 2009, en un hospital en la ciudad de Salvador (BA). El instrumento usado para la medición de la capacidad vital (CV) fue el espirómetro analógico y la elección de la secuencia de las posiciones siguió un orden aleatorio que se obtuvo a partir de un sorteo de las 4 posiciones. Los datos secundarios fueron extraídos de las historias clínicas de cada paciente. RESULTADOS: La muestra se compuso de 30 individuos con edades medias de 45,2 ± 11,2 años e IMC de 20,2 ± 1 kg/m2. La posición en ortostasis presentó valores mayores de CV con relación a la posición sedente (media de las diferencias: 0,15 ± 0,03 L; p = 0,001), al decúbito dorsal a 45° (media de las diferencias: 0,32 ± 0,04 L; p = 0,001) y a 0° (0,50 ± 0,05 L; p = 0,001). Hubo un aumento positivo entre los valores de CV forzada del decúbito dorsal para la postura ortostática (1,68 ± 0,47; 1,86 ± 0,48; 2,02 ± 0,48 y 2,18 ± 0,52 L, respectivamente). CONCLUSIÓN: La posición del cuerpo afecta los valores de la CV en pacientes durante el postoperatorio de cirugía abdominal superior, con aumento en las posturas en las que el tórax está verticalizado. .
Subject(s)
Humans , Arthritis, Rheumatoid/drug therapy , Computer Simulation , Cartilage, Articular/drug effects , Extracellular Matrix/drug effects , Models, Biological , Osteoarthritis/drug therapy , Arthritis, Rheumatoid/metabolism , Arthritis, Rheumatoid/pathology , Cartilage, Articular/metabolism , Cartilage, Articular/pathology , Extracellular Matrix/metabolism , Extracellular Matrix/pathology , Interleukin-1/pharmacology , Interleukin-1/therapeutic use , Oncostatin M/pharmacology , Oncostatin M/therapeutic use , Osteoarthritis/metabolism , Osteoarthritis/pathology , Signal TransductionABSTRACT
RATIONALE: The changes in body position can cause changes in lung function, it is necessary to understand them, especially in the postoperative upper abdominal surgery, since these patients are susceptible to postoperative pulmonary complications. OBJECTIVE: To assess the vital capacity in the supine position (head at 0° and 45°), sitting and standing positions in patients in the postoperative upper abdominal surgery. METHODS: A cross-sectional study conducted between August 2008 and January 2009 in a hospital in Salvador/BA. The instrument used to measure vital capacity (VC) was analogic spirometer, the choice of the sequence of positions followed a random order obtained from the draw of the four positions. Secondary data were collected from the medical records of each patient. RESULTS: The sample consisted of 30 subjects with a mean age of 45.2±11.2 years, BMI 20.2±1.0 kg/m(2). The position on orthostasis showed higher values of CV regarding standing (mean change: 0.15±0.03 liters; p=0.001), the supine to 45 (average difference: 0.32±0.04 liters; p=0.001) and 0° (0.50±0.05 liters; p=0.001). There was a positive trend between the values of FVC supine to upright posture (1.68±0.47; 1.86±0.48; 2.02±0.48 and 2.18±0.52 liters; respectively). CONCLUSION: Body position affects the values of CV in patients in the postoperative upper abdominal surgery, increasing in postures where the chest is vertical.
ABSTRACT
RATIONALE: The changes in body position can cause changes in lung function, and it is necessary to understand them, especially in the postoperative upper abdominal surgery, since these patients are susceptible to postoperative pulmonary complications. OBJECTIVE: To assess the vital capacity in the supine position (head at 0° and 45°), sitting and standing positions in patients in the postoperative upper abdominal surgery. METHODS: A cross-sectional study conducted between August 2008 and January 2009 in a hospital in Salvador/BA. The instrument used to measure vital capacity was analogic spirometer, the choice of the sequence of positions followed a random order obtained from the draw of the four positions. Secondary data were collected from the medical records of each patient. RESULTS: The sample consisted of 30 subjects with a mean age of 45.2 ± 11.2 years, BMI 20.2 ± 1.0 kg/m(2). The position on orthostasis showed higher values of vital capacity regarding standing (mean change: 0.15 ± 0.03 L; p=0.001), the supine to 45 (average difference: 0.32 ± 0.04 L; p = 0.001) and 0° (0.50 ± 0.05 L; p = 0.001). There was a positive trend between the values of forced vital capacity supine to upright posture (1.68 ± 0.47; 1.86 ± 0.48; 2.02 ± 0.48 and 2.18 ± 0.52 L; respectively). CONCLUSION: Body position affects the values of vital capacity in patients in the postoperative upper abdominal surgery, increasing in postures where the chest is vertical.
Subject(s)
Abdomen/surgery , Posture/physiology , Vital Capacity/physiology , Adult , Brazil , Cross-Sectional Studies , Female , Humans , Male , Middle Aged , Postoperative Complications/diagnosis , Postoperative Period , Spirometry , Supine Position/physiologyABSTRACT
Idiopathic pulmonary fibrosis (IPF) is a progressive and ultimately fatal lung disease that occurs in older adults. The clinical course of IPF is variable and hard to predict in an individual patient. Nintedanib is a tyrosine kinase inhibitor that has recently been approved in the US and European Union for the treatment of IPF. Preclinical studies have shown that nintedanib interferes with processes active in fibrosis such as fibroblast proliferation, migration and differentiation and the secretion of extracellular matrix. The safety and efficacy of nintedanib have been investigated in the phase II TOMORROW trial and in two replicate 52-week randomized, placebo-controlled phase III trials known as the INPULSIS trials. These trials demonstrated that nintedanib slowed disease progression by reducing the annual rate of decline in forced vital capacity, with a manageable side-effect profile. In this review, we summarize key data supporting nintedanib as a treatment for patients with IPF and address key questions regarding the use of nintedanib in the clinical setting.
Subject(s)
Enzyme Inhibitors/therapeutic use , Idiopathic Pulmonary Fibrosis/drug therapy , Indoles/therapeutic use , Adult , Clinical Trials as Topic , Drug Therapy, Combination , Humans , Patient Selection , Receptor Protein-Tyrosine Kinases/antagonists & inhibitorsABSTRACT
OBJECTIVE: To assess and compare long-term pulmonary outcomes in former preterm-born, very low birth weight (VLBW) children with and without bronchopulmonary dysplasia (BPD) born in the surfactant era. STUDY DESIGN: Pulmonary function tests (ie, spirometry, body plethysmography, and gas transfer testing) were performed in children with a history of VLBW and BPD (n = 28) and compared with a matched preterm-born VLBW control group (n = 28). Medical history was evaluated by questionnaire. RESULTS: At time of follow-up (mean age, 9.5 years), respiratory symptoms (36% vs 8%) and receipt of asthma medication (21% vs 0%) were significantly more frequent in the preterm-born children with previous BPD than in those with no history of BPD. The children with a history of BPD had significantly lower values for forced expiratory volume in 1 second (z-score -1.27 vs -0.4; P = .008), forced vital capacity (z-score -1.39 vs -0.71 z-score; P = .022), and forced expiratory flow rate at 50% of forced vital capacity (z-score -2.21 vs -1.04; P = .048) compared with the preterm control group. CONCLUSION: Preterm-born children with a history of BPD are significantly more likely to have lung function abnormalities, such as airway obstruction and respiratory symptoms, at school age compared with preterm-born children without BPD.
Subject(s)
Airway Obstruction/etiology , Asthma/etiology , Bronchopulmonary Dysplasia/physiopathology , Infant, Premature , Infant, Very Low Birth Weight , Lung/physiopathology , Airway Obstruction/epidemiology , Asthma/epidemiology , Bronchopulmonary Dysplasia/complications , Bronchopulmonary Dysplasia/diagnosis , Child , Female , Follow-Up Studies , Forced Expiratory Volume , Germany/epidemiology , Humans , Incidence , Male , Prognosis , Respiratory Function Tests , Retrospective Studies , Schools , Time Factors , Vital CapacityABSTRACT
BACKGROUND: Puerto Rican children share a disproportionate burden of prematurity and asthma in the United States. Little is known about prematurity and childhood asthma in Puerto Rican subjects. OBJECTIVE: We sought to examine whether prematurity is associated with asthma in Puerto Rican children. METHODS: We performed a case-control study of 678 children aged 6 to 14 years with (n = 351) and without (n = 327) asthma living in San Juan, Puerto Rico. Prematurity was defined by parental report for our primary analysis. In a secondary analysis, we only included children whose parents reported prematurity that required admission to the neonatal intensive care unit. Asthma was defined as physician-diagnosed asthma and wheeze in the prior year. We used logistic regression for analysis. All multivariate models were adjusted for age, sex, household income, atopy (≥1 positive IgE level to common allergens), maternal history of asthma, and early-life exposure to environmental tobacco smoke. RESULTS: In a multivariate analysis there was a significant interaction between prematurity and atopy on asthma (P = .006). In an analysis stratified by atopy, prematurity was associated with a nearly 5-fold increased odds of asthma in atopic children (adjusted odds ratio, 4.7; 95% CI, 1.5-14.3; P = .007). In contrast, there was no significant association between prematurity and asthma in nonatopic children. Similar results were obtained in our analysis of prematurity requiring admission to the neonatal intensive care unit and asthma. CONCLUSIONS: Our results suggest that atopy modifies the estimated effect of prematurity on asthma in Puerto Rican children. Prematurity might explain, in part, the high prevalence of atopic asthma in this ethnic group.
Subject(s)
Asthma/epidemiology , Hypersensitivity/epidemiology , Premature Birth/epidemiology , Adolescent , Asthma/ethnology , Case-Control Studies , Child , Female , Hispanic or Latino , Humans , Hypersensitivity/ethnology , Infant, Premature , Male , Pregnancy , Premature Birth/ethnologyABSTRACT
While administration of medical aerosols with heliox and positive airway pressure are both used clinically to improve aerosol delivery, few studies have differentiated their separate roles in treatment of asthmatics. The aim of this randomized, double blinded study is to differentiate the effect of heliox and oxygen with and without positive expiratory pressure (PEP), on delivery of radiotagged inhaled bronchodilators on pulmonary function and deposition in asthmatics. 32 patients between 18 and 65 years of age diagnosed with stable moderate to severe asthma were randomly assigned into four groups: (1) Heliox + PEP (n = 6), (2) Oxygen + PEP (n = 6), (3) Heliox (n = 11) and (4) Oxygen without PEP (n = 9). Each group received 1 mg of fenoterol and 2 mg of ipratropium bromide combined with 25 mCi (955 Mbq) of Technetium-99m and 0.9% saline to a total dose volume of 3 mL placed in a Venticis II nebulizer attached to a closed, valved mask with PEP of 0 or 10 cm H2O. Both gas type and PEP level were blinded to the investigators. Images were acquired with a single-head scintillation camera with the longitudinal and transverse division of the right lung as regions of interest (ROIs). While all groups responded to bronchodilators, only group 1 showed increase in FEV1%predicted and IC compared to the other groups (p < 0.04). When evaluating the ROI in the vertical gradient we observed higher deposition in the middle and lower third in groups 1 (p = 0.02) and 2 (p = 0.01) compared to group 3. In the horizontal gradient, a higher deposition in the central region in groups 1 (p = 0.03) and 2 (p = 0.02) compared to group 3 and intermediate region of group 2 compared to group 3. We conclude that aerosol deposition was higher in groups with PEP independent of gas used, while bronchodilator response with Heliox + PEP improved FEV1 % and IC compared to administration with Oxygen, Oxygen with PEP and Heliox alone. Trial registration NCT01268462.
Subject(s)
Anti-Asthmatic Agents/administration & dosage , Asthma/drug therapy , Bronchodilator Agents/administration & dosage , Ipratropium/administration & dosage , Adolescent , Adult , Aerosols/administration & dosage , Aged , Analysis of Variance , Anti-Asthmatic Agents/metabolism , Asthma/physiopathology , Bronchodilator Agents/metabolism , Drug Carriers/administration & dosage , Forced Expiratory Volume/drug effects , Forced Expiratory Volume/physiology , Helium/administration & dosage , Humans , Ipratropium/metabolism , Lung/metabolism , Middle Aged , Nebulizers and Vaporizers , Oxygen/administration & dosage , Positive-Pressure Respiration , Radiopharmaceuticals , Technetium Tc 99m Pentetate , Vital Capacity/drug effects , Young AdultABSTRACT
OBJECTIVE: To investigate the effectiveness of pulmonary rehabilitation (PR) in exercise capacity and quality of life in patients with chronic obstructive pulmonary disease (COPD) with and without global fat-free mass (FFM) depletion. DESIGN: Retrospective case-control. SETTING: Outpatient clinic, university center. PARTICIPANTS: COPD patients (N=102) that completed PR were initially evaluated. INTERVENTION: PR including whole-body and weight training for 12 weeks, 3 times per week. MAIN OUTCOME MEASURES: St. George Respiratory Questionnaire (SGRQ), 6-minute walk distance (6MWD), and FFM evaluation applied before and after PR. RESULTS: Patients were stratified according to their FFM status measured by bioelectric impedance. They were considered depleted if the FFM index was ≤ 15 kg/m(2) in women and ≤ 16 kg/m(2) in men. From the initial sample, all depleted patients (n=31) composed the FFM depleted group. It was composed predominantly by women (68%) with a mean age ± SD of 64.4 ± 7.3 years and a forced expiratory volume in 1 second of 33.6%=-13.2% predicted. Paired for sex and age, 31 nondepleted patients were selected from the initial sample to compose the nondepleted group. Improvement in the 6MWD was similar in these 2 groups after PR. Both groups improved SGRQ scores, although the observed power was small and did not allow adequate comparison between depleted and nondepleted patients. There was no difference between groups in weight change, whereas FFM tended to be greater in depleted patients. This increase had no correlation with the 6MWD or the SGRQ. CONCLUSIONS: Benefits of PR to exercise capacity were similar comparing FFM depleted and nondepleted COPD patients. Although FFM change tended to be greater in depleted patients, this increase had no definite relation with clinical outcomes.
Subject(s)
Exercise Tolerance/physiology , Muscular Atrophy/complications , Pulmonary Disease, Chronic Obstructive/complications , Pulmonary Disease, Chronic Obstructive/rehabilitation , Quality of Life , Body Mass Index , Female , Forced Expiratory Volume , Health Status , Humans , Male , Middle Aged , Muscular Atrophy/physiopathology , Muscular Atrophy/rehabilitation , Pulmonary Disease, Chronic Obstructive/physiopathology , Retrospective Studies , Surveys and Questionnaires , Treatment Outcome , Vital CapacityABSTRACT
OBJETIVO: determinar la función pulmonar y las condiciones de exposición a material particulado producido por dos fábricas en 264 residentes en el corregimiento La Sierra del municipio de Puerto Nare, departamento de Antioquia, en el 2008. METODOLOGIA: se realizó espirometría y se aplicó un cuestionario de síntomas respiratorios. Se midieron el material particulado menor de 10 micrómetros (PM10), la temperatura, la humedad, la dirección del viento y la precipitación en 6 meses. RESULTADOS: 7,2% de las personas presentó el porcentaje del volumen espiratorio forzado (VEF) menor de 70%; 27,7% y 28% presentaron el volumen espiratorio forzado del primer segundo (VEF1) y la capacidad vital forzada (CVF) menor de 80%. El mayor número de personas evaluadas con el %VEF < 70% vive en los cuatro barrios vecinos a las empresas. Se encontró asociación estadística entre un índice de masa corporal mayor de 25 y CVF < de 80% (p < 0,0009), tiempo de residencia y CVF < de 80%. La concentración promedio de PM10 durante el periodo de los seis meses fue de 42,1 µg/m³. La más alta fue de 142,89 µg/ m³. CONCLUSION: un importante porcentaje de la población tiene alteraciones en la función respiratoria, principalmente, quienes viven cerca de las empresas en presencia de concentraciones de PM10, consideradas de riesgo. Este es un problema grave de salud pública en sus componentes ambiental, de salud y de equidad social que no se está interviniendo adecuadamente, lo cual, de hacerse, sería una intervención que podría configurar un modelo para implementar políticas de protección a la población en lo referente a la exposición a contaminación ambiental.
OBJECTIVE: to determine lung function and the conditions of exposure to particulate matter produced by two factories among 264 residents in the township of La Sierra, in Puerto Nare municipality of Antioquia, in 2008. METHODOLOGY: spirometries were performed and a questionnaire of respiratory symptoms was applied. Particulate matter smaller than 10 micrometters (PM10), temperature, humidity, wind direction and precipitation during six months were measured. RESULTS: 7.2% of the people showed the lowest percentage of forced expiratory volume (FEV) below 70%. A total amount of 27.7% and 28% had FEV1 and forced vital capacity (FVC) below 80%. The largest number of people tested with the % FEV <70% lives in the four neighboring districts nearby the factories. Statistical association was found between body mass index greater than 25 and FVC < 80% (p < 0.0009), residence time and FVC < 80%. The average concentration of PM10 during the six month period was 42.1 ug/m³ and the highest was 142.89 mg/m³. CONCLUSION: a significant percentage of the population has alterations in their respiratory function, mainly those living near the factories showing concentrations of PM10 which is considered a hazard. All this means a serious public health problem according to its environmental, health and social equity components all of which are not being properly operated. It requires an appropriate intervention that should become a model to implement policies to protect the population in terms of exposure to environmental pollution.
Subject(s)
Spirometry , Vital Capacity , Particulate MatterABSTRACT
The present cross-sectional, population-based study was designed to evaluate the performance of the FEV1/FEV6 ratio for the detection of airway-obstructed subjects compared to the FEV1/FVC <0.70 fixed ratio test, as well as the lower limit of normality (LLN) for 1000 subjects ³40 years of age in the metropolitan area of São Paulo, SP, Brazil. After the exclusion of 37 (3.7 percent) spirometries, a total of 963 pre-bronchodilator (BD) and 918 post-BD curves were constructed. The majority of the post-BD curves (93.1 percent) were of very good quality and achieved grade A (762 curves) or B (93 curves). The FEV1/FEV6 and FEV1/FVC ratios were highly correlated (r² = 0.92, P < 0.000). Two receiver operator characteristic curves were constructed in order to express the imbalance between the sensitivity and specificity of the FEV1/FEV6 ratio compared to two FEV1/FVC cut-off points for airway obstruction: equal to 70 (area under the curve = 0.98, P < 0.0001) and the LLN (area under the curve = 0.97, P < 0.0001), in the post-BD curves. According to an FEV1/FVC <0.70, the cut-off point for the FEV1/FEV6 ratio with the highest sum for sensitivity and specificity was 0.75. The FEV1/FEV6 ratio can be considered to be a good alternative to the FEV1/FVC ratio for the diagnosis of airway obstruction, both using a fixed cut-off point or below the LLN as reference. The FEV1/FEV6 ratio has the additional advantage of being an easier maneuver for the subjects and for the lung function technicians, providing a higher reproducibility than traditional spirometry maneuvers.